Allergic and nonallergic interactions between house dust mite allergens and airway mucosa

European Respiratory Journal

Volumn 10, Issue 3, 1997, Pages 719-726

  Roche, N ^a   Chinet, T C ^a   Huchon, G J ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

airway epithelium; airway mucosa; allergy; asthma; house dust mite; proteinases

Indexed keywords

HOUSE DUST ALLERGEN; PROTEINASE;

ASTHMA; DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; HIGH RISK POPULATION; HOUSE DUST ALLERGY; HUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW;

ALLERGENS; ANIMALS; ASTHMA; DUST; ENVIRONMENTAL EXPOSURE; EPITHELIUM; HUMANS; MITES; MUCOUS MEMBRANE; PARTICLE SIZE; RISK FACTORS;

EID: 0031054773     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. National Heart Blood and Lung Institute. National Institute of Health International consensus report on diagnosis and treatment of asthma. Eur Respir J 1992; 5: 601-641.
2. Peat JK, Gray S, Woolcock AJ. The epidemiology of asthma. Curr Opin Pulm Med 1995; 1: 9-15.
3. Sporik R, Platts-Mills TAE. Epidemiology of dust mite related disease. Exp Appl Acar 1992; 16: 141-151.
4. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153: 141-146.
5. Hill AB. The environment and disease: association or causation? Proc Roy Soc Med 1965; 58: 295-300.
6. Platts-Mills TAE, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol 1987; 80: 755-775.
7. Platts-Mills TAE, De Weck A. Dust mite allergens and asthma: a worldwide problem. J Allergy Clin Immunol 1989; 83: 416-427.
8. Sporik R, Chapman MD, Platts-Mills TAE. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992; 22: 897-906.
9. Tonnel AB, Joseph M, Gosset P, Fournier E, Capron A. Stimulation of alveolar macrophages in asthmatic patients after local provocation test. Lancet 1983; 1: 1406-1408.
10. Parkos CA, Colgan SP, Delp C, Amaout MA, Madara JL. Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. J Cell Biol 1992; 117: 757-764.
11. Horn N, Lind P. Selection and characterization of monoclonal antibodies against a major allergen in Dermatophagoides pteronyssinus. Int Arch Allergy Appl Immunol 1987; 83: 404-409.
12. Chapman MD. Allergen-specific monoclonal antibodies: new tools for the management of allergic diseases. Allergy 1988; 43 (Suppl. 5): 7-14.
13. Chua KY, Stewart GA, Thomas WR, et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. J Exp Med 1988; 167: 175-182.
14. Dilworth RJ, Chua KY, Thomas WR. Sequence analysis of cDNA coding for a major house dust mite allergen, Der f I. Clin Exp Allergy 1991; 21: 25-32.
15. Tovey ER, Chapman MD, Platts-Mills TAE. Mite faeces are a major source of house dust allergens. Nature 1981; 289: 592-593.
16. Stewart GA, Lake FR, Bird CH, Thompson PJ. Mite allergens as digestive enzymes. In: Sehon AH, Kraft D, Kunkel G. eds. Epitopes of Atopic Allergens. Bruxelles, UCB, 1989; pp. 83-86.
17. Stewart GA, Thompson PJ, Simpson RJ. Protease antigens from house dust mite. Lancet 1989; ii: 154-155.
18. Stewart GA, Lake FR, Thompson PJ. Faecally-derived hydrolytic enzymes from Dermatophagoides pteronssinus: physicochemical characterisation of potential allergens. Int Arch Allergy Appl Immunol 1991: 95: 248-256.
19. Stewart GA, Ward LD Simpson RJ, Thompson PJ. The group III allergen from the house dust mite Dermatophagoides pteronssinus is a trypsin-like enzyme. Immunology 1992; 75: 29-35.
20. Thomas B, Heap P, Carswell F. Ultrastructural localization of the allergen Der p 1 in the gut of the house dust mite, Dermatophagoides pteronyssinus. Int Arch Allergy Appl Immunol 1991; 94: 365-367.
21. Yasueda H, Mita H, Akiyama K, et al. Allergens from Dermatophagoides mites with chymotryptic activity. Clin Exp Allergy 1993; 23: 384-390.
22. Hewitt CRA, Brown AP, Hart BJ, Pritchard DI. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 1995; 182: 1537-1544.
23. Stewart GA. Dust mite allergens. Clin Rev Allergy Immunol 1995; 13: 135-150.
24. Platts-Mills TAE, Sporik RB, Wheatley LM, Heymann PW. Is there a dose-response relationship between exposure to indoor allergens and symptoms of asthma? J Allergy Clin Immunol 1995; 96: 435-440.
25. Chan-Yeung M, Manfreda J, Dimich-Ward H, et al. Mite and cat allergen levels in homes and severity of asthma. Am J Respir Crit Care Med 1995; 152: 1805-1811.
26. Lau S, Falkenhorst G, Weber A, et al. High mite allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol 1989; 84: 718-725.
27. Korsgaard J. Mite asthma and residency: a case-control study on the impact of exposure to house dust mites in dwellings. Am Rev Respir Dis 1983; 128: 231-235.
28. Peat JK, Woolcock AJ. Sensitivity to common allergens: relation to respiratory symptoms and bronchial hyperresponsiveness in children from three different climatic areas of Australia. Clin Exp Allergy 1991; 21: 573-581.
29. Kuehr J, Fritscher T, Meinert R. Mite exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994; 94: 44-52.
30. Wickman M, Nordvall SL, Pershagen G, Sundell J, Schwartz B. House dust mite sensitization in children and residential characteristics in a temperate region. J Allergy Clin Immunol 1991; 88: 89-95.
31. Young RP, Hart BJ, Merrett TG, Read AF, Hopkin JM. House dust mite sensitivity: interaction of genetics and allergen dosage. Clin Exp Allergy 1992; 22: 205-211.
32. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house dust mite allergen (Der p1) and the development of asthma in childhood: a prospective study. N Engl J Med 1990; 323: 502-507.
33. Sherrill D, Sears MR, Lebowitz MD, et al. The effects of airway hyperresponsiveness, wheezing and atopy on longitudinal pulmonary function in children: a 6 year follow-up study. Pediatr Pulmonol 1992; 13: 78-85.
34. Charpin D, Kleisbauer JP, Lanteaume A, et al. Asthma and allergy to house dust mites in populations living in high altitudes. Chest 1988: 93: 758-761.
35. Vervloet D, Pradal M, Porri F, Charpin D. Epidémiologie de l'allergie aux acariens de la poussière de maison. Rev Mal Respir 1991; 8: 59-65.
36. Charpin D, Birnbaum J, Haddi E, et al. Altitude and allergy to house-dust mites: a paradigm of the influence of environmental exposure on allergic sensitization. Am Rev Respir Dis 1991; 143: 983-986.
37. Vervloet D, Charpin D, Haddi E, et al. Medication requirements and house dust mite exposure in mite-sensitive asthmatics. Allergy 1991; 46: 554-558.
38. Turner KJ, Stewart GA, Woolcock AJ, Green W, Alpers MP. Relationship between mite densities and the prevalence of asthma: comparative studies in two populations in the eastern highlands of Papua New Guinea. Clin Allergy 1988; 18: 331-340.
39. Dowse GK, Turner KJ, Stewart GA, Alpers MP, Woolcock AJ. The association between Dermatophagoides mites and the increasing prevalence of asthma in village communities within the Papua New Guinea highlands. J Allergy Clin Immunol 1985; 75: 75-83.
40. Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993; 23: 812-820.
41. Peat JK, van den Berg R, Green WF, Mellis CM, Leeder SR, Woolcock AJ. Changing prevalence of asthma in Australian children. BMJ 1994; 308: 1591-1595.
42. van der Heide S, de Monchy JGR, De vries K, Bruggink TM, Kauffman HF. Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma. J Allergy Clin Immunol 1994; 93: 470-475.
43. Murray AB, Ferguson AC. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics 1983; 71: 418-422.
44. Kniest FM, Young E, van Praag MCG, et al. Clinical evaluation of a double-blind dust mite avoidance trial with mite-allergic rhinitic patients. Clin Exp Allergy 1991; 21: 39-47.
45. Korsgaard J. Preventive measures in house dust allergy. Am Rev Respir Dis 1982; 125: 80-84.
46. Platts-Mills TAE, Mitchell EB, Nock P, Tovey ER, Moszoro H. Williams SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; 2: 675-677.
47. Dorward AJ, Colloff MJ, MacKay NS, MacSharry C, Thomson NC. Effect of house dust mite avoidance measures on adult atopic asthma. Thorax 1988; 43: 98-102.
48. Piacentini GL, Martinati L, Fomari A, et al. Antigen avoidance in a mountain environment: influence on basophil releasability in children with allergic asthma. J Allergy Clin Immunol 1993; 92: 644-650.
49. Hutson PA, Church MK, Clay TP, Miller P, Holgate ST. Early- and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea-pigs. I: The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis 1988; 137: 548-557.
50. Blyth DI, Pedrick MS, Savage TJ, Hessel EM, Fattah D. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol 1996; 14: 425-438.
51. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995: 151: 969-974.
52. Machiels JJ, Lebrun PM, Jacquemin MG, Saint-Remy JR. Significant reduction of nonspecific bronchial responsiveness in patients with Dermatophagoides pteronyssinus sensitive allergic asthma under therapy with allergen antibody complexes. Am Rev Respir Dis 1993; 147: 1407-1412.
53. Björksten B. Local immunotherapy is not documented for clinical use. Allergy 1994; 49: 299-301.
54. Rawle FC, Mitchell EB, Platts-Mills TAE. T-cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, antigen P 1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis. J Immunol 1984; 133: 195-201 .
55. O'Brien RM, Thomas WR, Wooton AM. T-cell responses to the purified major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1992; 89: 1021-1031.
56. Khirwadkar K, Schmitz M, Kabelitz D. Frequency analysis of allergen-reactive T-lymphocytes in individuals allergic against the house dust mite Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 1992; 98: 6-12.
57. Looney RJ, Pudiak D, Rosenfeld SI. Cytokine production by mite-specific T-cells from donors with mild atopic disease. J Allergy Clin Immunol 1994; 93: 476-483.
58. Yssel H, Johnson KE, Scheider PV, et al. T-cell activation-inducing epitopes of the house dust mite allergen, Der p 1. J Immunol 1992; 148: 738-745.
59. van Neerven RJJ, van t'Hof W, Ringrose JH, et al. T-cell epitopes of house dust mite major allergen, Der p 2. J Immunol 1993; 151: 2326-2335.
60. O'Hehir RE, Busch R, Rothbard JB, Lamb JR. An in vitro model of peptide-mediated immunomodulation of the human T-cell response to Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1991; 87: 1120-1127.
61. Higgins JA, Lamb JR, Marsh SGE, et al. Peptide-induced nonresponsiveness of HLA-DP restricted human T-cells reactive with Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1992; 90: 749-756.
62. Rawle FC, Platts-Mills TAE, Mitchell EB. Quantitative aspects of the T-cell proliferation response to antigen P1 from D. pteronyssinus: suppression by added histamine and limited effects of basophil depletion. Clin Exp Immunol 1985; 59: 101-109.
63. Gonzalez CM, Diaz P, Galleguillos FR, Ancic P, Cromwell O, Kay AB. Allergen-induced recruitment of bronchoalveolar helper (OKT4) And suppressor (OKT8) T-cells in asthma. Am Rev Respir Dis 1987; 136: 600-604.
64. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145: 1265-1269.
65. Diaz P, Gonzalez MC, Galleguillos FR, et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989; 139: 1383-1389.
66. Arnoux B, Joseph M, Simoes M, et al. Antigenic release of PAF-acether and beta-glycuronidase from alveolar macrophages of asthmatics. Bull Eur Physiopathol Respir 1987; 23: 119-124.
67. De Monchy JGR, Kauffman HK, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
68. Durham SR, Lee TH, Cromwell O, et al. Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 1984, 74: 49-60.
69. Gibson PG, Manning PJ, O'Byrne P, et al. Allergen-induced asthmatic responses: relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors. Am Rev Respir Dis 1991; 143: 331-335.
70. Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p 1. Am J Respir Crit Care Med 1995; 12: 369-378.
71. Azghani AO. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am J Respir Cell Mol Biol 1996; 15: 132-140.
72. Lemarchand P, Chinet T, Collignon MA, Urzua G, Barritault L, Huchon GJ. Bronchial clearance of DTPA is increased in acute asthma but not in chronic asthma. Am Rev Respir Dis 1992; 145: 147-152.
73. Huchon GJ. Radioaerosol studies of the pulmonary epithelium. In: Effros RM, Chang HK, eds. Fluid and Solute Transports in the Airspaces of the Lung. New York, Marcel Dekker Inc., 1994; 399-449.
74. Erjefalt JS, Sundler F, Persson CGA. Eosinophils, neutrophils, and venular gaps in the airway mucosa and epithelial removal restitution. Am J Respir Crit Care Med 1996; 153: 1666-1674.
75. Helm BA. Is there a link between the nature of agents that trigger mast cells and the induction of immunoglobulin (Ig)E synthesis? In: Atassi MZ, ed. Immunobiology of Proteins and Peptides. VII Edn. New York, Plenum Press, 1994; pp. 1-10.
76. Thompson AB, Robbins RA, Romberger DJ, et al. Immunological functions of the pulmonary epithelium. Eur Respir J 1995; 8: 127-149.
77. Boucher RC. Human airway ion transport: Part two. Am J Respir Crit Care Med 1994; 150: 581-593.
78. Somerhoff CP, Caughey GH, Finkbeiner WE. Lazarus SC, Basbaum CB, Nadel JA. Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989; 142: 2450-2456.
79. Somerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured airway gland serous cells. J Clin Invest 1990; 85: 682-689.
80. Tovey ER, Chapman MD, Wells CW, Plans-Mills TAE. The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis 1981; 124: 630-635.
81. Platts-Mills TAE, Heymann PW, Longbottom JL, Wilkins SR. Airborne allergens associated with asthma: particle sizes carrying dust mite and rat allergens measured with a cascade impactor. J Allergy Clin Immunol 1986; 77: 850-857.
82. Svartengren M, Falk R, Linnman L, Philipson K, Camner P. Deposition of large particles in human lung. Exp Lung Res 1987; 12: 75-88.
83. Ferguson P, Broide DH. Environmental and bronchoalveolar lavage Dermatophagoides pteronyssinus antigen levels in atopic asthmatics. Am J Respir Crit Care Med 1995; 151: 71-74.